[go: up one dir, main page]

JPS59172417A - Soft capsule containing riboflavin butyrate - Google Patents

Soft capsule containing riboflavin butyrate

Info

Publication number
JPS59172417A
JPS59172417A JP4710983A JP4710983A JPS59172417A JP S59172417 A JPS59172417 A JP S59172417A JP 4710983 A JP4710983 A JP 4710983A JP 4710983 A JP4710983 A JP 4710983A JP S59172417 A JPS59172417 A JP S59172417A
Authority
JP
Japan
Prior art keywords
riboflavin butyrate
forming agent
film
pigment
tocopherol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP4710983A
Other languages
Japanese (ja)
Other versions
JPH0237890B2 (en
Inventor
Takeo Iijima
飯島 健雄
Takahisa Maruyama
丸山 孝久
Kayoko Arai
荒井 加代子
Masaharu Sakaguchi
坂口 正晴
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nisshin Chemical Co Ltd
Original Assignee
Nisshin Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nisshin Chemical Co Ltd filed Critical Nisshin Chemical Co Ltd
Priority to JP4710983A priority Critical patent/JPS59172417A/en
Publication of JPS59172417A publication Critical patent/JPS59172417A/en
Publication of JPH0237890B2 publication Critical patent/JPH0237890B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

PURPOSE:To obtain the titled transparent soft capsule stable to light and having beautiful appearance, by coating a drug containing riboflavin butyrate useful as a remedy for arteriosclerosis and a tocopherol compound with a film-forming agent containing a specific pigment. CONSTITUTION:A drug containing riboflavin butyrate and a tocopherol compound is coated with a film-forming agent containing a pigment capable of absorbing the light of 300-500nm, preferably 400-500nm in wavelength (e.g. Food Yellow 5, Food Yellow 4, beta-carotene, etc.). Food Yellow 5 is especially suitable as the pigment. The addition of the pigment of the film-forming agent enables to avoid the decomposition of riboflavin butyrate simultaneously to the melanization caused by the photo-reduction reaction of riboflavin butyrate with tocopherol. The tocopherol is effective to mitigate the disorder of the peripheral blood flow.

Description

【発明の詳細な説明】 本発明は有効成分としてリボフラビン酪酸エステルおよ
びトコフェロール類を含有する透明な軟カプセルに関す
る。    ′ リボフラビン酪酸エステルは、動脈硬化症の予防および
治療にすぐれた効果を有することが知られており、粉体
状で錠剤、顆粒または散剤としてか、あるいは油に溶解
して軟カプセル剤として使用されている。本発明者らは
リボフラビン酪酸エステルに末梢血行障害の緩オロ5等
の目的でトコフェロール類ヲ混合して軟カプセル剤を調
製したところ、長期間保存したものおよび褐色容器に保
存せずに数週間室内散乱光下に保存したものが黒色化現
象を呈し、商品価値が全くなくなることを知つ′17−
9 本発明者らはこれらの欠点を解決すべく種々研究を重ね
た結果、本発明を完成するに至った。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to transparent soft capsules containing riboflavin butyrate and tocopherols as active ingredients. ' Riboflavin butyrate is known to have excellent effects on the prevention and treatment of arteriosclerosis, and is used in powder form as tablets, granules, or powders, or dissolved in oil as soft capsules. ing. The present inventors prepared soft capsules by mixing riboflavin butyrate with tocopherols for the purpose of slowing down peripheral blood circulation disorder. I learned that items stored under scattered light exhibit a blackening phenomenon and lose their commercial value.'17-
9 The present inventors have conducted various studies to solve these drawbacks, and as a result, have completed the present invention.

すなわち、本発明はりボッ2ビン醋酸エステルおよびト
コフェロール類を含有する薬剤を300〜550 nm
の光を吸収する色素を含んだ皮膜形成剤で被包してなる
リボフラビン酪酸エステルを含有した透明軟カプセルで
ある。
That is, the drug containing the present invention's acetic acid ester and tocopherols was applied at a wavelength of 300 to 550 nm.
This is a transparent soft capsule containing riboflavin butyrate encapsulated with a film-forming agent containing a pigment that absorbs light.

本発明者らの知見によれば、前記の黒変化現象はリボフ
ラビン酪酸エステルのトコフェロ、−ル類による光還元
反応の結果として生起されるものである。さらにリボフ
ラビン酪酸エステルは、油液中で油中のリノール酸等に
由来する過酸化物によシ分解されることも明らかとなっ
た。
According to the findings of the present inventors, the aforementioned blackening phenomenon occurs as a result of the photoreduction reaction of riboflavin butyrate ester with tocopherols. Furthermore, it has been revealed that riboflavin butyrate is decomposed in oil by peroxides derived from linoleic acid, etc. in oil.

そこで本発明者らは、これらの黒変化現象およびリボフ
ラビン酸酪エステルの分解を同時に回避する手段として
、皮膜形成剤中に300〜550nm好ましくは400
〜500 nmの光を吸収する色素を含有せしめること
によp1光に対して安定で外観の美しい透明な軟カプセ
ル剤が得られることを見出した。
Therefore, the present inventors added 300 to 550 nm, preferably 400 nm, to the film forming agent as a means to simultaneously avoid these blackening phenomena and the decomposition of riboflavic acid butyester.
It has been found that by containing a dye that absorbs light of ~500 nm, transparent soft capsules that are stable against p1 light and have a beautiful appearance can be obtained.

まず、本発明の軟カプセルの製造のためには、リボフラ
ビン酪酸エステルおよびトコフェロール類を油に混合溶
解して軟カプセル充填用油液を得る。
First, in order to produce the soft capsules of the present invention, riboflavin butyrate and tocopherols are mixed and dissolved in oil to obtain an oil liquid for filling soft capsules.

この充填用油液は、例えば2枚の帯状の皮膜形成剤の間
に充填し、両側から金型で押圧することによって軟カプ
セルを調製することができる。軟カプセルの調製方法と
しては自動ロータリ一式、半自動コルトン式、手動平盤
式などが採用できる。軟カプセルの形状も球形、楕円形
各種々の形態とすることができる。
Soft capsules can be prepared by filling this filling oil liquid between, for example, two belt-shaped film-forming agents and pressing the film-forming agent from both sides with a mold. As a method for preparing soft capsules, an automatic rotary set, a semi-automatic Colton method, a manual flat plate method, etc. can be adopted. The shape of the soft capsule can also be variously spherical or elliptical.

本発明に使用する油としては例えば小麦胚芽油、コメ油
、サフラワー油、大豆油、菜種油、コーン油、落花生油
、炭素数4〜18の脂肪酸のモノ、ジおよびトリエステ
ルまたはこれらの混合物が挙げられる。また、所望によ
り甘味料、香料等の添加物を適宜加えることもできる。
Examples of the oils used in the present invention include wheat germ oil, rice oil, safflower oil, soybean oil, rapeseed oil, corn oil, peanut oil, mono-, di- and triesters of fatty acids having 4 to 18 carbon atoms, or mixtures thereof. Can be mentioned. Additionally, additives such as sweeteners and flavoring agents can be added as appropriate.

軟カプセルのための皮膜形成剤としては例えばゼラチン
が挙げられるが、軟カプセル内へ大気中の水分が移行す
るのを防止するためにゼラチンに対してソルビトールを
10〜30%、好ましくは15〜25%の範囲で使用す
るのが好ましい。また色素の添加量は皮膜の重量に対し
て0.4〜1%である。
Examples of film-forming agents for soft capsules include gelatin, but in order to prevent atmospheric moisture from migrating into the soft capsules, sorbitol is added in an amount of 10 to 30%, preferably 15 to 25%, based on gelatin. It is preferable to use it in the range of %. The amount of the pigment added is 0.4 to 1% based on the weight of the film.

本発明におけるリボフラビン酪酸エステルとトコフェロ
ール類との配合割合は、リボフラビン酪酸エステルに対
してトコフェロール類4〜20倍の範囲が好ましい。使
用するトコフェロ/”#4!:L、テtj:a−α−ト
コフェロール、dJ−α−トコフェロール、酢酸d−α
−トコフェロール、天然トコフェロールCMTO)など
が挙げられる。
In the present invention, the ratio of riboflavin butyrate to tocopherols is preferably 4 to 20 times that of riboflavin butyrate. Tocopherol used/”#4!: L, Tetj: a-α-tocopherol, dJ-α-tocopherol, acetic acid d-α
-tocopherol, natural tocopherol (CMTO), and the like.

また、600〜500r+mに光の吸収を有する色素と
しては食用黄色5号、食用黄色4号、クチナシ(クロシ
ン)、β−カロチン、サフラワーイエロー、クルクミン
などが挙げられるが、なかでも食用黄色5号が特に優れ
ている。これらの色素は皮膜形成剤中に均一に分散させ
て使用する。
In addition, examples of pigments that absorb light at 600 to 500 r+m include Food Yellow No. 5, Food Yellow No. 4, gardenia (crocin), β-carotene, safflower yellow, and curcumin, among which Food Yellow No. 5 is particularly good. These dyes are used after being uniformly dispersed in a film forming agent.

次に本発明ヲ史に具体的に示すために実施例金挙げて茜
兄明する。
Next, in order to concretely illustrate the history of the present invention, examples will be given and explained.

実施例 1 後記第1表に示す各成分全加温溶解して均一なカプセル
充填用油液とした。また第2表に示す各成分を混合し加
温溶解して皮膜形成剤を調製した。
Example 1 All of the components shown in Table 1 below were dissolved by heating to obtain a uniform oil solution for filling capsules. Further, each component shown in Table 2 was mixed and dissolved by heating to prepare a film forming agent.

前記の充填用油液および皮膜形成剤を用い、自動ロータ
リ一式カゾセ、ル充填機によシ軟カプセルを製造した。
Soft capsules were manufactured using the above-mentioned filling oil and film-forming agent using an automatic rotary type filling machine.

得られた軟カプセルを晴天日ヲ選んで直射日光下(0,
0459θrg/錆2・min )に7日間保存して外
観変化を截察した。その試験結果を示せば第6表のとお
りである。
The obtained soft capsules were placed on a sunny day under direct sunlight (0,
0459θrg/rust 2·min) for 7 days, and changes in appearance were observed. The test results are shown in Table 6.

第2表 軟カプセル皮膜形成剤処方 実施例 2 後記第4表に示す各成分を加温俗解して均一なカプセル
充填用油液とした。また第5表に示す各成分′Jt混合
し加訊溶解して皮膜形成剤を調製した。
Table 2 Soft Capsule Film Forming Agent Prescription Example 2 Each component shown in Table 4 below was heated to obtain a uniform oil solution for filling capsules. Further, each component shown in Table 5 was mixed and dissolved to prepare a film forming agent.

前記の充填用油液および皮膜形成剤を用い、自動ロータ
リ一式カプセル充填機により軟カプセルを製造した。
Soft capsules were manufactured using the above-mentioned filling oil and film forming agent using an automatic rotary capsule filling machine.

得られた軟カプセルを晴天臼を選んで直射日光下に7日
間保存して外観変化を観察した。その試験結果を示せば
第6表のとおりである。
The obtained soft capsules were stored under direct sunlight for 7 days in a sunny mortar, and changes in appearance were observed. The test results are shown in Table 6.

第4表 軟カプセル充填用油液処方 第5表 軟カプセル皮膜形成剤処方Table 4 Oil liquid formulation for soft capsule filling Table 5 Soft capsule film forming agent formulation

Claims (1)

【特許請求の範囲】[Claims] リボフラビン酪酸エステルおよびトコフェロール類を含
有する薬剤を600〜550nmの光を吸収する色素を
含んだ皮膜形成剤で被包したことを特徴とする、リボフ
ラビン酪酸エステルを含有する軟カプセル。
A soft capsule containing riboflavin butyrate, characterized in that a drug containing riboflavin butyrate and tocopherols is encapsulated with a film-forming agent containing a pigment that absorbs light in the wavelength range of 600 to 550 nm.
JP4710983A 1983-03-23 1983-03-23 Soft capsule containing riboflavin butyrate Granted JPS59172417A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP4710983A JPS59172417A (en) 1983-03-23 1983-03-23 Soft capsule containing riboflavin butyrate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4710983A JPS59172417A (en) 1983-03-23 1983-03-23 Soft capsule containing riboflavin butyrate

Publications (2)

Publication Number Publication Date
JPS59172417A true JPS59172417A (en) 1984-09-29
JPH0237890B2 JPH0237890B2 (en) 1990-08-28

Family

ID=12766008

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4710983A Granted JPS59172417A (en) 1983-03-23 1983-03-23 Soft capsule containing riboflavin butyrate

Country Status (1)

Country Link
JP (1) JPS59172417A (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6187620A (en) * 1984-10-05 1986-05-06 Nisshin Kagaku Kk Transparent compounded drug preparation of vitamin b2 butyric acid ester for soft capsule
JPS6425715A (en) * 1987-04-13 1989-01-27 Ono Pharmaceutical Co Novel pharmaceutical containing esters or amides as active ingredient
JPH04193825A (en) * 1990-11-26 1992-07-13 Nippon Eranko Kk Hard gelatin capsule
WO1992017173A2 (en) * 1991-04-02 1992-10-15 Jean Berque Use of riboflavin for treating hiv-related diseases, herpes, retinitis pigmentosa and malaria
WO2000050029A1 (en) * 1999-02-23 2000-08-31 Chugai Seiyaku Kabushiki Kaisha Seam soft capsule preparations containing dihydrobenzofuran derivative
WO2002013819A1 (en) * 2000-08-16 2002-02-21 Chugai Seiyaku Kabushiki Kaisha Seamless soft capsule preparations containing dihydrobenzofuran derivatives
FR2837670A1 (en) * 2002-03-26 2003-10-03 Longechaud Veronique Fernandez GELATIN CAPSULES CONTAINING OIL FROM ITS PURE RICE OR ENRICHED WITH ANY CHEMICAL OR NATURAL COMPOSITION FOR NUTRITIONAL SUPPLEMENT
US7713523B2 (en) 2003-09-29 2010-05-11 Soft Gel Technologies, Inc. Solubilized CoQ-10 and carnitine
US8506995B2 (en) * 1999-03-29 2013-08-13 Soft Gel Technologies, Inc. Coenzyme Q10 formulation and process methodology for soft gel capsules manufacturing
US10166192B2 (en) 2003-09-29 2019-01-01 Soft Gel Technologies, Inc. Solubilized CoQ-10
US10314793B2 (en) 2003-09-29 2019-06-11 Soft Gel Technologies, Inc. Solubilized CoQ-10

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6187620A (en) * 1984-10-05 1986-05-06 Nisshin Kagaku Kk Transparent compounded drug preparation of vitamin b2 butyric acid ester for soft capsule
JPS6425715A (en) * 1987-04-13 1989-01-27 Ono Pharmaceutical Co Novel pharmaceutical containing esters or amides as active ingredient
JP2537658B2 (en) * 1987-04-13 1996-09-25 小野薬品工業株式会社 Novel formulation containing ester or amide as active ingredient
JPH04193825A (en) * 1990-11-26 1992-07-13 Nippon Eranko Kk Hard gelatin capsule
WO1992017173A2 (en) * 1991-04-02 1992-10-15 Jean Berque Use of riboflavin for treating hiv-related diseases, herpes, retinitis pigmentosa and malaria
WO2000050029A1 (en) * 1999-02-23 2000-08-31 Chugai Seiyaku Kabushiki Kaisha Seam soft capsule preparations containing dihydrobenzofuran derivative
US8506995B2 (en) * 1999-03-29 2013-08-13 Soft Gel Technologies, Inc. Coenzyme Q10 formulation and process methodology for soft gel capsules manufacturing
WO2002013819A1 (en) * 2000-08-16 2002-02-21 Chugai Seiyaku Kabushiki Kaisha Seamless soft capsule preparations containing dihydrobenzofuran derivatives
FR2837670A1 (en) * 2002-03-26 2003-10-03 Longechaud Veronique Fernandez GELATIN CAPSULES CONTAINING OIL FROM ITS PURE RICE OR ENRICHED WITH ANY CHEMICAL OR NATURAL COMPOSITION FOR NUTRITIONAL SUPPLEMENT
US7713523B2 (en) 2003-09-29 2010-05-11 Soft Gel Technologies, Inc. Solubilized CoQ-10 and carnitine
US10166192B2 (en) 2003-09-29 2019-01-01 Soft Gel Technologies, Inc. Solubilized CoQ-10
US10166193B2 (en) 2003-09-29 2019-01-01 Soft Gel Technologies, Inc. Method of making a soft gel capsule comprising CoQ-10 solubilized in a monoterpene
US10314793B2 (en) 2003-09-29 2019-06-11 Soft Gel Technologies, Inc. Solubilized CoQ-10

Also Published As

Publication number Publication date
JPH0237890B2 (en) 1990-08-28

Similar Documents

Publication Publication Date Title
US3655406A (en) Carotenoid compositions
JPS59172417A (en) Soft capsule containing riboflavin butyrate
CN110075081A (en) A kind of soft capsule and preparation method thereof and purposes
JPS5953410A (en) Novel soft capsule agent
JPS63501150A (en) microcapsule
JPH0361403B2 (en)
KR880002512A (en) Ethanol Formulation Filling Softgels Containing Vitamins, Dietary Supplements, and Similars
EP1028714B1 (en) Vitamin composition
JP2001279100A (en) Gelatin solid substance
WO2017114120A1 (en) Vitamin and carotenoid powder and preparation method and use thereof
JPS603045B2 (en) Method for producing 1α-hydroxyvitamin D soft capsules
US2952548A (en) Protopectin composition and method of preparation
JPS63166824A (en) Soft capsule
US2548970A (en) Liquid lip-rouge composition
WO1987000429A1 (en) Opaque light-stable and possibly coloured gelatine products and method for their production
JPS6110508A (en) Capsule and its production
US3183108A (en) Plastic type modeling compound
CN115067522A (en) Choline-containing multivitamin and mineral composition and preparation method and application thereof
JPH01186815A (en) Soft capsule agent and production thereof
CN112715933A (en) Royal jelly capsule and preparation method thereof
JP3640005B2 (en) Soft capsule coating
JPS6226214A (en) Warm water gradually soluble solid bath composition
JPS63295507A (en) Method for producing stabilized formulations
JPH08140624A (en) Nutrition auxiliary food
JP5110848B2 (en) Formulation containing diphenhydramine salt